WHAT IS THE FUTURE OF VALUE-BASED CARE?

Commercial risk will be a critical catalyst of progress – it’s complicated, but is it possible? We think so.

X

Research

What is changing life sciences market dynamics in 2022?

    Advisory Board and Optum Life Sciences recently collaborated to identify eleven trends that life sciences leaders must watch. In this first article of our three-part series, we’ll take a closer look at the first four trends that are changing life sciences market dynamics in 2022:

    • The coming wave of next-gen therapies
    • Continued battles over drug pricing
    • The pursuit of health equity
    • Efforts to democratize clinical trials
    Other reports in this series

    This report is part of our market trends series for life sciences leaders in 2022. Check out the other trends:

    Part 2: Sources and uses of evidence
    Part 3: Organizational impacts

    Download the full report

    • Trend 1: The coming wave of next-gen therapies
    • Trend 2: Continued battles over drug pricing
    • Trend 3: The pursuit of health equity
    • Trend 4: Efforts to democratize clinical trials

    More customer insights

    For more customer insights that will shape life sciences leaders' priorities in 2022, check out: The top customer trends that life sciences leaders need to know about in 2022.

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.